| Abdelrahman Aly, MD | |
|
1025 Marsh St, Mankato, MN 56001-4752 | |
| (507) 625-4031 | |
| Not Available |
| Full Name | Abdelrahman Aly |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 20 Years |
| Location | 1025 Marsh St, Mankato, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295001196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | D0085664 (Maryland) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 68774 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Health System - Mankato | Mankato, MN | Hospital |
| Mayo Clinic Hospital Rochester | Rochester, MN | Hospital |
| Mayo Clinic Health System - Fairmont | Fairmont, MN | Hospital |
| Mayo Clinic Health System - Waseca | Waseca, MN | Hospital |
| Mayo Clinic Health System - St James | St james, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-southwest Minnesota Region | 4688585771 | 533 |
| Mayo Clinic Health System-fairmont | 4981694981 | 132 |
| Mayo Clinic | 6507778255 | 4232 |
| Mayo Clinic Health System St James | 9537170352 | 47 |
News Archive
A vexing problem in the development of vaccines has been the need to achieve the right glycosylation profile for the viral antigens. A new study, recently released as a preprint on the bioRxiv* server, shows how a sequential cell-free approach produced complex N-glycans from simpler types, in a one-pot reaction.
Lucideon, the international materials technology company, along with its partners on the ReBioStent project, will be hosting a satellite session, "Bioresorbable Materials for Medical Applications", at the European Society of Biomaterials (ESB) conference 2015 in Krakow, Poland on the 2nd of September.
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
Minneapolis Star Tribune: "Gov. Tim Pawlenty wrote U.S. DHS Secretary Kathleen Sebelius Tuesday to ask for cash. The letter, in which Pawlenty requested Medicaid and foster care cash, the governor also bashed the federal health care overhaul." He "told the secretary that his order was fueled by concern about 'overspending' and 'unbearable burdens that spending will place on our economy.'
› Verified 2 days ago
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
A vexing problem in the development of vaccines has been the need to achieve the right glycosylation profile for the viral antigens. A new study, recently released as a preprint on the bioRxiv* server, shows how a sequential cell-free approach produced complex N-glycans from simpler types, in a one-pot reaction.
Lucideon, the international materials technology company, along with its partners on the ReBioStent project, will be hosting a satellite session, "Bioresorbable Materials for Medical Applications", at the European Society of Biomaterials (ESB) conference 2015 in Krakow, Poland on the 2nd of September.
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
Minneapolis Star Tribune: "Gov. Tim Pawlenty wrote U.S. DHS Secretary Kathleen Sebelius Tuesday to ask for cash. The letter, in which Pawlenty requested Medicaid and foster care cash, the governor also bashed the federal health care overhaul." He "told the secretary that his order was fueled by concern about 'overspending' and 'unbearable burdens that spending will place on our economy.'
› Verified 2 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545422 PECOS PAC ID: 4688585771 Enrollment ID: O20031110000134 |
News Archive
A vexing problem in the development of vaccines has been the need to achieve the right glycosylation profile for the viral antigens. A new study, recently released as a preprint on the bioRxiv* server, shows how a sequential cell-free approach produced complex N-glycans from simpler types, in a one-pot reaction.
Lucideon, the international materials technology company, along with its partners on the ReBioStent project, will be hosting a satellite session, "Bioresorbable Materials for Medical Applications", at the European Society of Biomaterials (ESB) conference 2015 in Krakow, Poland on the 2nd of September.
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
Minneapolis Star Tribune: "Gov. Tim Pawlenty wrote U.S. DHS Secretary Kathleen Sebelius Tuesday to ask for cash. The letter, in which Pawlenty requested Medicaid and foster care cash, the governor also bashed the federal health care overhaul." He "told the secretary that his order was fueled by concern about 'overspending' and 'unbearable burdens that spending will place on our economy.'
› Verified 2 days ago
| Entity Name | Mayo Clinic Health System-fairmont |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366410862 PECOS PAC ID: 4981694981 Enrollment ID: O20040719000142 |
News Archive
A vexing problem in the development of vaccines has been the need to achieve the right glycosylation profile for the viral antigens. A new study, recently released as a preprint on the bioRxiv* server, shows how a sequential cell-free approach produced complex N-glycans from simpler types, in a one-pot reaction.
Lucideon, the international materials technology company, along with its partners on the ReBioStent project, will be hosting a satellite session, "Bioresorbable Materials for Medical Applications", at the European Society of Biomaterials (ESB) conference 2015 in Krakow, Poland on the 2nd of September.
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
Minneapolis Star Tribune: "Gov. Tim Pawlenty wrote U.S. DHS Secretary Kathleen Sebelius Tuesday to ask for cash. The letter, in which Pawlenty requested Medicaid and foster care cash, the governor also bashed the federal health care overhaul." He "told the secretary that his order was fueled by concern about 'overspending' and 'unbearable burdens that spending will place on our economy.'
› Verified 2 days ago
| Entity Name | Mayo Clinic Health System St James |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023177730 PECOS PAC ID: 9537170352 Enrollment ID: O20060509000021 |
News Archive
A vexing problem in the development of vaccines has been the need to achieve the right glycosylation profile for the viral antigens. A new study, recently released as a preprint on the bioRxiv* server, shows how a sequential cell-free approach produced complex N-glycans from simpler types, in a one-pot reaction.
Lucideon, the international materials technology company, along with its partners on the ReBioStent project, will be hosting a satellite session, "Bioresorbable Materials for Medical Applications", at the European Society of Biomaterials (ESB) conference 2015 in Krakow, Poland on the 2nd of September.
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
Minneapolis Star Tribune: "Gov. Tim Pawlenty wrote U.S. DHS Secretary Kathleen Sebelius Tuesday to ask for cash. The letter, in which Pawlenty requested Medicaid and foster care cash, the governor also bashed the federal health care overhaul." He "told the secretary that his order was fueled by concern about 'overspending' and 'unbearable burdens that spending will place on our economy.'
› Verified 2 days ago
| Entity Name | Mayo Clinic Health System St James |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1639198732 PECOS PAC ID: 9537170352 Enrollment ID: O20080108000344 |
News Archive
A vexing problem in the development of vaccines has been the need to achieve the right glycosylation profile for the viral antigens. A new study, recently released as a preprint on the bioRxiv* server, shows how a sequential cell-free approach produced complex N-glycans from simpler types, in a one-pot reaction.
Lucideon, the international materials technology company, along with its partners on the ReBioStent project, will be hosting a satellite session, "Bioresorbable Materials for Medical Applications", at the European Society of Biomaterials (ESB) conference 2015 in Krakow, Poland on the 2nd of September.
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
Minneapolis Star Tribune: "Gov. Tim Pawlenty wrote U.S. DHS Secretary Kathleen Sebelius Tuesday to ask for cash. The letter, in which Pawlenty requested Medicaid and foster care cash, the governor also bashed the federal health care overhaul." He "told the secretary that his order was fueled by concern about 'overspending' and 'unbearable burdens that spending will place on our economy.'
› Verified 2 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1740256668 PECOS PAC ID: 4688585771 Enrollment ID: O20171011003933 |
News Archive
A vexing problem in the development of vaccines has been the need to achieve the right glycosylation profile for the viral antigens. A new study, recently released as a preprint on the bioRxiv* server, shows how a sequential cell-free approach produced complex N-glycans from simpler types, in a one-pot reaction.
Lucideon, the international materials technology company, along with its partners on the ReBioStent project, will be hosting a satellite session, "Bioresorbable Materials for Medical Applications", at the European Society of Biomaterials (ESB) conference 2015 in Krakow, Poland on the 2nd of September.
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
Minneapolis Star Tribune: "Gov. Tim Pawlenty wrote U.S. DHS Secretary Kathleen Sebelius Tuesday to ask for cash. The letter, in which Pawlenty requested Medicaid and foster care cash, the governor also bashed the federal health care overhaul." He "told the secretary that his order was fueled by concern about 'overspending' and 'unbearable burdens that spending will place on our economy.'
› Verified 2 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1124035282 PECOS PAC ID: 4688585771 Enrollment ID: O20171011003939 |
News Archive
A vexing problem in the development of vaccines has been the need to achieve the right glycosylation profile for the viral antigens. A new study, recently released as a preprint on the bioRxiv* server, shows how a sequential cell-free approach produced complex N-glycans from simpler types, in a one-pot reaction.
Lucideon, the international materials technology company, along with its partners on the ReBioStent project, will be hosting a satellite session, "Bioresorbable Materials for Medical Applications", at the European Society of Biomaterials (ESB) conference 2015 in Krakow, Poland on the 2nd of September.
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
Minneapolis Star Tribune: "Gov. Tim Pawlenty wrote U.S. DHS Secretary Kathleen Sebelius Tuesday to ask for cash. The letter, in which Pawlenty requested Medicaid and foster care cash, the governor also bashed the federal health care overhaul." He "told the secretary that his order was fueled by concern about 'overspending' and 'unbearable burdens that spending will place on our economy.'
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abdelrahman Aly, MD 13950 Brandywine Rd Ste 100, Brandywine, MD 20613-5815 Ph: () - | Abdelrahman Aly, MD 1025 Marsh St, Mankato, MN 56001-4752 Ph: (507) 625-4031 |
News Archive
A vexing problem in the development of vaccines has been the need to achieve the right glycosylation profile for the viral antigens. A new study, recently released as a preprint on the bioRxiv* server, shows how a sequential cell-free approach produced complex N-glycans from simpler types, in a one-pot reaction.
Lucideon, the international materials technology company, along with its partners on the ReBioStent project, will be hosting a satellite session, "Bioresorbable Materials for Medical Applications", at the European Society of Biomaterials (ESB) conference 2015 in Krakow, Poland on the 2nd of September.
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
Minneapolis Star Tribune: "Gov. Tim Pawlenty wrote U.S. DHS Secretary Kathleen Sebelius Tuesday to ask for cash. The letter, in which Pawlenty requested Medicaid and foster care cash, the governor also bashed the federal health care overhaul." He "told the secretary that his order was fueled by concern about 'overspending' and 'unbearable burdens that spending will place on our economy.'
› Verified 2 days ago
Ripudamanjit Singh, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Stephan Thome, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Suresh Devineni, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1230 E Main St, Mankato, MN 56001 Phone: 507-625-1811 | |
Diana Franco Corso, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Manpreet Kanwar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1230 E Main St, Mankato Clinic, Mankato, MN 56002 Phone: 507-625-1811 | |
Birendra S Kumar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1230 E Main St, Mankato Clinic At Main Street, Mankato, MN 56001 Phone: 507-625-1811 | |
Kingsley Iheasirim, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 |